Venous thromboembolism (VTE) is an important cause of mortality and morbidity in critical care patients. This is as a result of high prevalence of VTE risk factors in this group of patients including physical inactivity, immobilization, vascular injury and / or hypercoagulable state. The effect of these risk factors are cumulative 1, 2, 3 . VTE may progress into thrombophebitis or pulmonary embolism (PE) with increased mortality and morbidity and have enormous economic issues. But the risk of VTE and its prevention have been poorly characterized in this population. Evidence based thromboembolic prophylaxis guidelines are also not widely available for these critically ill patients 3,4 . The main objectives of this audit were to determine the presence and the type of the risk factors and the prophylaxis given in patients admitted to five adult intensive care units (ICU) in National Hospital Sri Lanka (NHSL).
Background:
VTE is a major cause of mortality and morbidity in both hospital and community setting, causing an estimated 60,000 deaths per year in UK 5 . Within this population up to 25,000 are potentially preventable with implementation of VTE preventive strategies 5 . Deep vein thrombosis (DVT) and PE contribute significantly to mortality and morbidity associated with critical illness.
Among patients who died in ICU, PE has been reported in 7-27% (mean 13%) of post mortem examinations, and PE was thought to have caused or contributed to death in 0-12% (mean 3%); although a clinical suspicion on PE was present in only 30% of these patients before death 3 . Cross-sectional studies of medical and surgical intensive care unit patients have shown that approximately 10% of the patients have DVT on admission to the ICU 4 . The majority of patients admitted to the critical care units, carries major risk factors for VTE and most have multiple risk factors. Many of these risk factors for VTE precede ICU admission while in others they develop during the course of their stay in ICU. Advancing age, recent surgical procedures, malignancy, trauma and past history of DVT are some of the risk factors they carry on admission. Patients are further predisposed to DVT during their ICU stay due to prolonged immobilization, sepsis, vascular injuries from indwelling central venous catheters and other invasive interventions, heart failure, mechanical ventilation and paralysis. The importance of each of these clinical risk factors is unknown, as is the role of inherited or acquired coagulation system abnormalities 3, 4 .
Pharmacological and/or mechanical prophylaxis against DVT is recommended for this high risk population. These have shown efficacious in preventing DVT compared with no prophylaxis. 14 studies over this matter have reported that compliance with some form of thromboprophylaxis occurred in 33-100% of critically ill patients in ICU 3 .
The main objectives of this audit were to determine the presence and the type of the risk factors and the prophylaxis given in patients admitted to five adult ICUs in NHSL.
Material and method:
The audit was carried out from 1 st to 31 st March 2011, in 5 adult ICUs -Medical (MICU), Surgical (SICU), Cardiac (CICU), Trauma (TICU) and Obstetric (OICU) attached to NHSL.
Ethical consideration:
Confidentiality was maintained. The care of patients was not affected by the audit.
Audit setting and the population:
There were altogether 31 beds (SICU-8, MICU-8, OICU-3, TICU-6 and CICU-6) in the 5 ICUs. Admission policy and the type of patients were different from one another as each of these were specialized ICUs. Total study population comprised 90 patients.
Data collection and the method:
Data were obtained through data collection forms which were filled by a postgraduate trainee in anaesthesiology and critical care, appointed to the relevant ICU during that particular period. Patients' records, drug chart and direct questioning from the conscious patients were the added sources of data.
The risk factors looked for were as follows: Age >60 yrs, obesity (BMI>30), history of VTE, acquired or inherited bleeding disorders, history of malignancy and treatment, oral contraceptives or hormone replacement therapies, history of peripheral vascular disease, prolonged immobility, recent major surgery and history of prolonged travel before or after surgery.
1

Analysis of the data:
Following areas were addressed during the analysis of the data. Risk factors for VTE Contraindications for VTE prophylaxis Common methods of VTE prophylaxis
Results:
During the period of one month 90 patients were audited. Total patients: 90 Table 3 Age Group Number 10 -20 years 10 20 -40 years 36
-60 years 26
60 -80 years 17
>80 years 01
Total patients: 90 Obstetrics & Gynecology 17
Abdominal 09
Trauma and orthopedic 05
Other general 03 Total patients: 90 Total patients: 90 Total patients: 39 Total patients: 51 Total patients: 51 Total patients:16
Discussion: Out of total 90 patients, least number was recorded from the SICU 13% (12 patients). This might be due to the lower rate of patient turnover in SICU during that time. 20-40 year age group contributed mainly for the study population (40%). This may be due to the contribution from the child bearing age group from the OICU and its higher patient turnover. Majority (49%) of the study population was admitted following surgery. This is probably as we have audited 4 surgical based ICUs. Among other common reasons for the admission to the critical care unit were, systemic illness with organ failure (22%), trauma (15.5%) and heart disease complicating pregnancy (8.8%).
Among the post operative population, following surgeries belonged to the high risk category for DVT risk; major general surgeries (oesophagectomy, abdomino perineal resection, thyroidectomy and Whipple's procedure), orthopedic (kyposcoliosis correction) and major vascular surgeries (kidney transplant) 1 . Except 2 thyroidectomies and 1 kidney transplant all other patients had received both mechanical and pharmacological prophylaxis. Two patients who underwent thyroidectomy had not received any mode of VTE prophylaxis (they had been mobilized out of bed on post operative day 1) while the kidney transplant patient had received only pharmacological prophylaxis.
According to the 2006 October NICE guidelines on VTE prophylaxis for high risk surgical patients, all patients who are undergoing high risk surgeries (major general surgery, vascular surgery, gynecological surgery, urological surgery, neurological surgery and cardiac surgery) should receive mechanical prophylaxis. If these patients carry one or more risk factors they should be offered both mechanical and pharmacological prophylaxis (low molecular weight heparin / fondaparinux). Patients with elective major orthopedic surgeries should receive both type of prophylaxis irrespective of the number of the risk factors 1 .
Cardiac surgeries fall in to the high risk for VTE, but majority of those patients were not put on VTE prophylaxis. Early mobilization and the fact that patients with valvular surgeries were started on anticoagulants during immediate post operative period, might be the reasons for why they did not receive VTE prophylaxis.
Majority of patients admitted to a critical care unit has a major risk factor for VTE, and most have multiple risk factors. Many of these thrombosis risk factors precede the ICU admission, while others develop during the course of ICU stay. The importance of each of these clinical risk factors is unknown, as is the role of inherited or acquired coagulation system abnormalities. However, adequately powered studies using multiple logistic regression analysis to determine the independent predictors for thrombosis in critically ill patients have not yet been conducted. 3 A double-blind, placebo-controlled, randomized trial on DVT prophylaxis has been performed in 791 medical ICU patients; thrombosis was detected by Doppler ultrasound examinations performed every 3 days. DVT was diagnosed in 31% of the 390 control patients, and 5% had PE.
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In our study population (90 patients) 57% (51 patients) had not received VTE prophylaxis while 43% (38 patients) had received it. Looking for the distribution of the risk factors in the study population 39 patients (43%) had at least 2 risk factors for VTE. 6 patients ( 8% ) were found to have >4 risk factors for VTE. But only 3 out of those 6 patients received VTE prophylaxis. 17 out of 39 patients who received VTE prophylaxis had 2 risk factors for VTE while 25 patients who did not receive VTE prophylaxis, also had 2 risk factors for VTE.
Despite the paucity of critical care-specific data about thromboembolism, the risks of VTE in other patient groups, including surgical, trauma/spinal cord injury, and medical patients, are well established and are relevant to those in critical care units. Objectively confirmed DVT rates were found to be in the range of 10 to 80% for patients admitted to ICUs or following trauma, neurosurgery, or spinal cord injury in a recent systematic review. 3 Acute liver failure (21%) was the commonest risk factor for bleeding (contra indication for pharmacological VTE prophylaxis). thrombocytopenia and INR > 2 were the other risk factors encountered. Above 3 contra indications were consistently found in the patients with multi organ dysfunction following sepsis highlighting the importance of frequent assessment of the risk and benefit of pharmacological VTE prophylaxis among the critical care population.
Peripheral arterial bypass graft and severe leg oedema were the two identified commonest contra indications for the use of anti embolic stockings.
One of the objectives of this study was to assess the incidences of VTE prophylaxis usage in the critical care set up in NHSL Colombo. 57% (51 patients) had not been given any form of VTE prophylaxis. Out of these 51 patients 62.7% (32 patients), had no contraindications for pharmacological or mechanical VTE prophylaxis methods. 22% of patients had contra indications for pharmacological prophylaxis, 8% had contra indications for mechanical prophylaxis and another 8% had contra indications for both. 68.7% of patients who had not been given VTE prophylaxis had more than one risk factor for VTE (5 patients had > 4 risk factors for VTE), while the other 10 patients had only one (admission to critical care unit).
• 7 out of these 10 patients were mobilized out of bed within 24 hours.
• 6 of them belonged to 20 -40 yr age group.
• None of them had a BMI >30kg/m 2 • 2 were post thyroidectomy patients • 01 patient was with a combined spinal epidural • 02 were for observation following trauma These might be the reasons why they were not given VTE prophylaxis. 39 patients out of this 51 (76.4%) were audited during the 1 st and 2 nd day of admission to the critical care unit. This might be another reason why these patients were not started on VTE prophylaxis.
In 39 patients who were treated with VTE prophylaxis, 43.5% (17 patients) received only pharmacological prophylaxis as the mechanical devices were not available. Unavailability of the mechanical VTE prophylaxis devices (graduated compression stockings, sequential compression devices, foot pumps) in critical care units is one of the draw backs which we think need to be addressed.
Enoxaparin 40mg daily was the regime used mostly irrespective of the patient's body weight. Only 2 patients were treated with calculated dose according to the BW. Enoxaparin 60mg daily and 60 mg twice a day were the other common regimes used. Currently accepted anticoagulant agents in VTE prophylaxis are unfractionated heparin, low molecular weight heparin, oral direct factor Xa inhibitors, warfarin, aspirin and fondaparinux. 1, 2 Graduated compression stockings are also considered as effective as pharmacological prophylaxis. Other forms of mechanical methods include electrical stimulation of the calf muscles and intermittent external pneumatic compression devices. 1, 2 Most of the post operative patients who were started on VTE prophylaxis were started 8-12 hours after surgery (43.7%) which correctly matches with the guidelines. Starting VTE prophylaxis in 12-24hr post op period was 18.7% and >24hr post op period 25%. One of the reasons for delayed start of pharmacological prophylaxis
